Literature DB >> 4041831

Local cerebral glucose utilization in the free moving mouse: a comparison during two stages of the activity-rest cycle.

T M Jay, M Jouvet, M H des Rosiers.   

Abstract

The 2-deoxy-D[1-14C]glucose ([14C]DG) technique has been applied to the free moving mouse for the quantitative determination of local cerebral glucose utilization (LCGU). Reproducible values for LCGU were obtained indicating that the [14C]DG method had a sufficient resolution power to allow visualization and quantification of very small structures provided that glucose and [14C]DG plasma concentrations were measured on microsamples, autoradiographs prepared from proper tissue sections and suitable techniques used for analysis of the maps thus obtained. LCGU was measured in free moving mice during two stages of the light-dark cycle, one corresponding to a period of rest and the other to a period of high motor activity. In the two groups of animals LCGU was heterogeneous in the grey matter, the highest values being found in the auditory regions, the cerebellar and vestibular nuclei. LCGU was found to be lower in drowsy animals during the day than in active animals during the night and the difference was significant in the 8 following structures: the sensorimotor cortex, the septal nuclei, the nucleus of the olfactory tract, the basal amygdaloid nucleus, the ventral nucleus of the thalamus, the lateral geniculate body, the medial geniculate body and the auditory cortex. On the contrary, the suprachiasmatic nucleus was very active during the day and relatively inactive during the night as previously reported in the rat.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4041831     DOI: 10.1016/0006-8993(85)91129-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Learning-induced change in neural activity during acquisition and consolidation of a passive avoidance response in the rat.

Authors:  E Doyle; P M Nolan; C M Regan
Journal:  Neurochem Res       Date:  1990-05       Impact factor: 3.996

Review 2.  Circadian regulation of membrane physiology in neural oscillators throughout the brain.

Authors:  Jodi R Paul; Jennifer A Davis; Lacy K Goode; Bryan K Becker; Allison Fusilier; Aidan Meador-Woodruff; Karen L Gamble
Journal:  Eur J Neurosci       Date:  2019-01-29       Impact factor: 3.386

3.  Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation.

Authors:  Mei Qin; Julia Kang; Carolyn Beebe Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-11       Impact factor: 11.205

4.  Local cerebral glucose utilization in the autoimmune New Zealand black (NZB) mouse.

Authors:  A Wree; T Beck; G W Bielenberg; A Schleicher; K Zilles
Journal:  Histochemistry       Date:  1989

5.  Regionally selective decreases in cerebral glucose metabolism in a mouse model of phenylketonuria.

Authors:  M Qin; C Beebe Smith
Journal:  J Inherit Metab Dis       Date:  2007-04-24       Impact factor: 4.982

6.  Deletion of the STOP gene, a microtubule stabilizing factor, leads only to discrete cerebral metabolic changes in mice.

Authors:  Ryosuke Hanaya; Estelle Koning; Arielle Ferrandon; Annie Schweitzer; Annie Andrieux; Astrid Nehlig
Journal:  J Neurosci Res       Date:  2008-03       Impact factor: 4.164

Review 7.  Mapping brain function in freely moving subjects.

Authors:  Daniel P Holschneider; Jean-Michel I Maarek
Journal:  Neurosci Biobehav Rev       Date:  2004-09       Impact factor: 8.989

8.  A 24-hour temporal profile of in vivo brain and heart pet imaging reveals a nocturnal peak in brain 18F-fluorodeoxyglucose uptake.

Authors:  Daan R van der Veen; Jinping Shao; Sarah Chapman; W Matthew Leevy; Giles E Duffield
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

Review 9.  Glycogen metabolism and the homeostatic regulation of sleep.

Authors:  Jean-Marie Petit; Sophie Burlet-Godinot; Pierre J Magistretti; Igor Allaman
Journal:  Metab Brain Dis       Date:  2014-11-16       Impact factor: 3.584

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.